These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 2459218)

  • 21. Comparison of the expression of IL 2 receptors by human T and B cells: induction by the polyclonal mitogens, phorbol myristate acetate, and anti-mu antibody.
    Suzuki T; Cooper MD
    J Immunol; 1985 May; 134(5):3111-9. PubMed ID: 2580014
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Monoclonal antibodies to the human C3b/C4b receptor (CR1) enhance specific B cell differentiation.
    Weiss L; Delfraissy JF; Vazquez A; Wallon C; Galanaud P; Kazatchkine MD
    J Immunol; 1987 May; 138(9):2988-93. PubMed ID: 2952731
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Structure and signalling functions of C3 receptors on human B cells.
    Frade R
    Semin Immunol; 1990 Mar; 2(2):159-64. PubMed ID: 2151800
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Monocyte-independent stimulation of human B lymphocytes by phorbol myristate acetate.
    Bertoglio JH
    J Immunol; 1983 Nov; 131(5):2279-81. PubMed ID: 6605383
    [TBL] [Abstract][Full Text] [Related]  

  • 25. CR2 is a complement activator and the covalent binding site for C3 during alternative pathway activation by Raji cells.
    Mold C; Nemerow GR; Bradt BM; Cooper NR
    J Immunol; 1988 Mar; 140(6):1923-9. PubMed ID: 2831273
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Characterization of lymphokines mediating B cell growth and differentiation from monoclonal anti-CD3 antibody-stimulated T cells.
    Sherris D; Stohl W; Mayer L
    J Immunol; 1989 Apr; 142(7):2343-51. PubMed ID: 2538506
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Activation of human B cells: alternate options for initial triggering and effects of nonmitogenic concentrations of anti-IgM antibodies on resting and activated cells.
    Smeland EB; Beiske K; Ohlsson R; Holte H; Ruud E; Blomhoff HK; Jefferis R; Godal T
    J Immunol; 1987 May; 138(10):3179-84. PubMed ID: 3553323
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Inhibition of B cell growth factor (BCGF) by monoclonal antibodies directed against the C3d receptor (CR2).
    Perri RT; Wilson BS; Kay NE
    Eur J Immunol; 1986 Apr; 16(4):350-5. PubMed ID: 2938967
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Evidence for multiple sites of interaction in C3 for complement receptor type 2 (C3d/EBV receptor, CD21).
    Esparza I; Becherer JD; Alsenz J; De la Hera A; Lao Z; Tsoukas CD; Lambris JD
    Eur J Immunol; 1991 Nov; 21(11):2829-38. PubMed ID: 1834472
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Antibody to a novel 95-kDa surface glycoprotein on human B cells induces calcium mobilization and B cell activation.
    Valentine MA; Clark EA; Shu GL; Norris NA; Ledbetter JA
    J Immunol; 1988 Jun; 140(12):4071-8. PubMed ID: 3259604
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cognate interactions between helper T cells and B cells. III. Contact-dependent, lymphokine-independent induction of B cell cycle entry by activated helper T cells.
    Noelle RJ; McCann J; Marshall L; Bartlett WC
    J Immunol; 1989 Sep; 143(6):1807-14. PubMed ID: 2476483
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Analysis of epitope expression and the functional repertoire of recombinant complement receptor 2 (CR2/CD21) in mouse and human cells.
    Carel JC; Frazier B; Ley TJ; Holers VM
    J Immunol; 1989 Aug; 143(3):923-30. PubMed ID: 2473114
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Neutrophils express a receptor for iC3b, C3dg, and C3d that is distinct from CR1, CR2, and CR3.
    Vik DP; Fearon DT
    J Immunol; 1985 Apr; 134(4):2571-9. PubMed ID: 3156185
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Antibodies to the common leukocyte antigen (T200) inhibit an early phase in the activation of resting human B cells.
    Mittler RS; Greenfield RS; Schacter BZ; Richard NF; Hoffmann MK
    J Immunol; 1987 May; 138(10):3159-66. PubMed ID: 2952710
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Antibodies reactive with class II antigens encoded for by the major histocompatibility complex inhibit human B cell activation.
    Clement LT; Tedder TF; Gartland GL
    J Immunol; 1986 Apr; 136(7):2375-81. PubMed ID: 3485149
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Anti-HLA class I antibodies inhibit the T cell-independent proliferation of human B lymphocytes.
    Taylor DS; Nowell PC; Kornbluth J
    J Immunol; 1987 Sep; 139(6):1792-6. PubMed ID: 3497978
    [TBL] [Abstract][Full Text] [Related]  

  • 37. IL-4/B cell stimulatory factor 1 stimulates T cell growth by an IL-2-independent mechanism.
    Brown M; Hu-Li J; Paul WE
    J Immunol; 1988 Jul; 141(2):504-11. PubMed ID: 3133410
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cooperation between an anti-T cell (anti-CD28) monoclonal antibody and monocyte-produced IL-6 in the induction of T cell responsiveness to IL-2.
    Baroja ML; Ceuppens JL; Van Damme J; Billiau A
    J Immunol; 1988 Sep; 141(5):1502-7. PubMed ID: 3261751
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Modulation of the p27kip1 cyclin-dependent kinase inhibitor expression during IL-4-mediated human B cell activation.
    Blanchard DA; Affredou MT; Vazquez A
    J Immunol; 1997 Apr; 158(7):3054-61. PubMed ID: 9120257
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Characterization of C3dg binding to a recess formed between short consensus repeats 1 and 2 of complement receptor type 2 (CR2; CD21).
    Prodinger WM; Schwendinger MG; Schoch J; Köchle M; Larcher C; Dierich MP
    J Immunol; 1998 Nov; 161(9):4604-10. PubMed ID: 9794388
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.